Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

London Seed Capital

Dec 2007
The London Seed Capital investment fund, the London Business Angels and the Catapult Venture Managers have awarded Michelson Diagnostics Ltd. of Orpington, UK, £600,000 of early-stage funding to pursue in vivo clinical trials of real-time cancer imaging technology. The project aims to enable faster and more accurate cancer surgeries. With the technology, the company expects that surgeons will be able to see a tumor’s size and location, assess its margin and spread, and create better outcomes.

Biophotonicsimaging technologyLondon Seed CapitalNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.